Our publications

Identifying late onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks gestation.

Whitehead CL, McNamara H, Walker SP, Alexiadis M, Fuller P, Vickers DK, Hastie R, Tuohey L, Hannan NJ, Kaitu’u-Lino TJ, ...

Placental insufficiency in fetuses that slow in growth but are born appropriate for gestational age: A prospective longitudinal study.

Bardien N, Whitehead CL, Tong S, Ugoni A, McDonald D, Walker SP. PLoS One 2016; 11(1): e0142788.

Measuring hypoxia-induced RNA in maternal blood: a new way to identify critically hypoxic fetuses in utero?

Whitehead CL, Tong S. Expert Reviews in Molecular Diagnostics 2014; 14(5):509-11.

Quantifying circulating hypoxia-induced RNA transcripts in maternal blood to determine in utero fetal hypoxic status.

Whitehead CL, Teh WT, Walker SP, Leung C, Mendis S, Lamour L, Tong S. BMC Medicine 2013; 11:256.

Circulating MicroRNAs as potential biomarkers for fetal hypoxia in utero.

Whitehead CL, Teh WT, Walker SP, Leung C, Larmour L, Tong S. PLoS One 2013; 8(11): e78487.

Quantifying mRNA coding growth genes in the maternal circulation to detect fetal growth restriction.

Whitehead C, Walker SP, Mendis S, Lappas M, Tong S. American Journal of Obstetrics and Gynecology 2013; 209(2): 133.e1-9

Circulating RNA coding genes regulating apoptosis in maternal blood in severe early onset fetal growth restriction and pre-eclampsia.

Whitehead C, Walker SP, Lappas M, Tong S. Journal of Perinatology 2013; 33(8):600-4.

Placental specific mRNA in the maternal circulation are globally dysregulated in pregnancies complicated by fetal growth restriction.

Whitehead CL, Walker SP, Ye L, Mendis S, Kait’u-Lino T, Lappas M, Tong S. Journal of Clinical Endocrinology and Metaboli...

Circulating Delta-like homolog 1 (DLK1) at 36 weeks is correlated with birthweight and is placental origin

The untapped potential of placenta-enriched molecules for diagnostic and therapeutic development